Latest news
Fosun Pharma Subsidiary Wins China Approval for Heart Failure Injection - TipRanksTipRanks · Sat, 08 Aug 2026 05:38:24 GMTFosun Pharma Wins NMPA Approval for New Levosalbutamol Nebuliser Therapy - TipRanksTipRanks · Sat, 08 Aug 2026 02:25:21 GMTFosun program reaches 25,000 rural doctors, 3M families - Stock TitanStock Titan · Thu, 06 Aug 2026 05:03:40 GMTShanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF) Q4 2023 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Tue, 04 Aug 2026 12:58:57 GMTFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 10:26:00 GMTFosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in China - TipRanksTipRanks · Mon, 03 Aug 2026 10:52:46 GMT